Pfizer Inc. (PFE/NYSE): general review
08 August 2018, 13:34Scenario | |
---|---|
Timeframe | Intraday |
Recommendation | BUY STOP |
Entry Point | 41.10 |
Take Profit | 42.00, 42.50, 43.50 |
Stop Loss | 40.00 |
Key Levels | 38.25, 39.00, 40.00, 41.00, 42.50 |
Alternative scenario | |
---|---|
Recommendation | SELL STOP |
Entry Point | 39.90 |
Take Profit | 38.50, 38.00 |
Stop Loss | 41.00 |
Key Levels | 38.25, 39.00, 40.00, 41.00, 42.50 |
Current trend
Pfizer shares grew by 5.2% since the publication of a strong quarterly report on July 31 and updated the 52-week high at the trading session on August 6. Adjusted earnings per share rose by 31% (YoY) to USD 0.81, exceeding Wall Street's expectations of USD 0.75. Revenue also showed an increase of 4% (YoY) to USD 13.47 billion (higher than market expectations). Pfizer raised its earnings per share forecast in 2018 to USD 2.95-3.05 and, at the same time, slightly lowered its revenue forecast due to the negative impact of exchange rate differences in view of the strengthening US dollar.
During the previous week, Pfizer stock grew by 2.28%. S&P500 went up by 1.49% within the same period.
Support and resistance
The company's shares demonstrate a clear upward trend. At the moment, #PFE quotes are testing annual highs. The instrument has the potential to further growth. Indicators show the strength of the buyers. the price is above MA(50) and MA(200); MACD is in the positive zone. Positions are better to be opened in line with the main trend.
Comparing company's multiplier with its competitors, we can say that #PFE shares are neutral.
Resistance levels: 41.00, 42.50.
Support levels: 40.00, 39.00, 38.25.

Trading tips
If the price consolidates above the level of 41.00, one should expect the company's shares to grow. Potential profits should be locked in by orders at 42.00, 42.50 and 43.50. Stop loss – 40.00.
If the price consolidates below the level of 40.00, one should expect a correction. The moving potential is aimed at 38.50–38.00. Stop loss – 41.00.
Implementation time: 3 days.
Pfizer shares grew by 5.2% since the publication of a strong quarterly report on July 31 and updated the 52-week high at the trading session on August 6. Adjusted earnings per share rose by 31% (YoY) to USD 0.81, exceeding Wall Street's expectations of USD 0.75. Revenue also showed an increase of 4% (YoY) to USD 13.47 billion (higher than market expectations). Pfizer raised its earnings per share forecast in 2018 to USD 2.95-3.05 and, at the same time, slightly lowered its revenue forecast due to the negative impact of exchange rate differences in view of the strengthening US dollar.
During the previous week, Pfizer stock grew by 2.28%. S&P500 went up by 1.49% within the same period.
Support and resistance
The company's shares demonstrate a clear upward trend. At the moment, #PFE quotes are testing annual highs. The instrument has the potential to further growth. Indicators show the strength of the buyers. the price is above MA(50) and MA(200); MACD is in the positive zone. Positions are better to be opened in line with the main trend.
Comparing company's multiplier with its competitors, we can say that #PFE shares are neutral.
Resistance levels: 41.00, 42.50.
Support levels: 40.00, 39.00, 38.25.

Trading tips
If the price consolidates above the level of 41.00, one should expect the company's shares to grow. Potential profits should be locked in by orders at 42.00, 42.50 and 43.50. Stop loss – 40.00.
If the price consolidates below the level of 40.00, one should expect a correction. The moving potential is aimed at 38.50–38.00. Stop loss – 41.00.
Implementation time: 3 days.
No comments:
Write comments